Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 6,918 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Hand Transplantation, Peripheral Nerve Injuries, Neurologic Rehabilitation
Interventions: Transcranial Direct Current Stimulation, Modified Constraint Induced Movement Therapy; Device · Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 3
States / cities: Louisville, Kentucky • Columbia, Missouri • St Louis, Missouri

Conditions: Visual Impairment
Interventions: Standard object battery and training sequence, VIS4ION System; Behavioral · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Sclerosis
Interventions: RT 300: Lower Extremity Cycling; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Subarachnoid Hemorrhage, Aneurysmal
Interventions: gammaCore; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Low Back Pain
Interventions: Lumbar MB RFN; Device
Lead sponsor: Nimbus Concepts, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Greenwood Village, Colorado

Conditions: Extragonadal Germ Cell Tumor, Ovarian Cancer
Interventions: dactinomycin, filgrastim, carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, leucovorin calcium, methotrexate, vincristine sulfate, conventional surgery; Biological · Drug · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Up to 20 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2002
U.S. locations: 1
States / cities: New York, New York

Conditions: Social Behavior Disorders, Neurodevelopmental Disorders
Interventions: Melillo Method; Procedure
Lead sponsor: Life University; Other
Eligibility: 8 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Roodhouse, Illinois

Conditions: Metastatic Melanoma, Metastasis to Brain
Interventions: Nivolumab, Ipilimumab, Nivolumab + Relatlimab, Standard of Care Craniotomy; Drug · Procedure
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Tampa, Florida • Houston, Texas

Conditions: Depression, OCD, Anxiety Depression
Interventions: Patients treated with NeuroStar TMS, Patients treated with Esketamine; Device · Drug
Lead sponsor: Neuronetics; Other
Eligibility: 5 Years to 100 Years
Enrollment: 12,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Malvern, Pennsylvania

Conditions: Neutropenia, Breast Cancer
Interventions: Eflapegrastim, Docetaxel, Cyclophosphamide; Biological · Drug
Lead sponsor: Spectrum Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 8
States / cities: Tucson, Arizona • Yuma, Arizona • Anaheim, California + 5 more

Conditions: Inappropriate Sinus Tachycardia
Interventions: electrophysiology study and radiofrequency ablation; Procedure
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 80 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2020
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Dystonia Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Knee Osteoarthritis
Interventions: BEST™ HVPC microcurrent electrical stimulation Pro-Sport Ultra® device; Device
Lead sponsor: Avazzia, Inc; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Stroke
Interventions: Neuromuscular Electrical Stimulation, Sham Electrical Stimulation; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injury Cervical
Interventions: Activity based upper extremity training with and without stimulation; Device
Lead sponsor: University of Louisville; Other
Eligibility: 7 Years to 12 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Essential Tremor
Interventions: Deep Brain Stimulation; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Parkinson's Disease, Essential Tremor
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Aurora, Colorado

Conditions: Urinary Urgency Incontinence
Interventions: Neuspera Implantable Sacral Nerve Stimulation System; Device
Lead sponsor: Neuspera Medical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 31
States / cities: Encinitas, California • Los Angeles, California • San Diego, California + 27 more

Conditions: Osteoarthritis of Knee, Edema, Wounds and Injuries
Interventions: ODIN1, Standard Care, Diagnostic Device Testing; Device · Other
Lead sponsor: Bioelectric Research Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 2
States / cities: Las Vegas, Nevada

Conditions: Dystrophic Epidermolysis Bullosa
Interventions: Granulocyte Colony Stimulating Factor (GCSF); Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Not listed
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Parkinson's Disease
Interventions: Deep brain stimulation, Electroencephalography; Device · Other
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Graves' Disease
Interventions: IMVT-1402, Placebo; Drug
Lead sponsor: Immunovant Sciences GmbH; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 33
States / cities: Tucson, Arizona • Concord, California • Aurora, Colorado + 28 more

Conditions: Post Partum Depression
Interventions: iTBS; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Lymphoma
Interventions: filgrastim, busulfan, cyclophosphamide, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: AIDS Malignancy Consortium; Network
Eligibility: 18 Years to 120 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 2
States / cities: Baltimore, Maryland • Boston, Massachusetts

Search by objective public record fields.

Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair

Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices

Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS

Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage

Technical Efficacy of a Direction Specific Radiofrequency Device in the Performance of Lumbar Medial Branch Neurotomies

Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors

The Effects of the Melillo Method® on Biopsychosocial Outcomes in School-Age Children

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Ablation of Inappropriate Sinus Tachycardia

Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia

Veteran Affairs Osteoarthritis Knee Study

Electrical Stimulation After Botulinum Toxin Injections to the Upper Extremity

Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury

Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract

Optimizing DBS Electrode Placement and Programming

Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)

Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Accelerated iTBS for Post Partum Depression

Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma